Our systematic review revealed that most evidence exists for transthoracic echocardiogram (TTE), pulmonary function tests, and NT-ProBNP for screening and diagnosis of systemic sclerosis-PAH; however, more robust studies are needed. PubMed, Semin Arthritis Rheum. 2013 Sep 5. (Also see: Pulmonary Hypertension Diagnosis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.